TY - JOUR
T1 - Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism
AU - Fujioka, Shinsuke
AU - Wszolek, Zbigniew K.
N1 - Funding Information:
Acknowledgments SF is partially funded by Mayo Clinic Florida (MCF) Research Committee CR program (MCF no. 90052018). ZKW is partially supported by the NIH/NINDS 1RC2NS070276, NS057567, P50NS072187, Mayo Clinic Florida (MCF) Research Committee CR programs (MCF no. 90052018 and MCF no. 90052030), and the gift from Carl Edward Bolch, Jr., and Susan Bass Bolch (MCF no. 90052031/PAU no. 90052).
Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2011/11
Y1 - 2011/11
N2 - Frontotemporal dementia is the second most common dementia among people under the age of 65. Fifty percent of affected patients have an associated family history. Several pathogenic genes have been identified for frontotemporal dementia associated with parkinsonism, including microtubule-associated protein tau, progranulin, and chromatin modifying protein 2B, and fused in sarcoma. It has also been reported that frontotemporal dementia associated with parkinsonism can be linked to chromosome 9p. In addition, there are families with frontotemporal dementia associated with a parkinsonian phenotype but unknown genetic status. Some of these kindreds have been diagnosed clinically as familial progressive supranuclear palsy, hereditary diffuse leukoencephalopathy with axonal spheroids, "overlap" syndrome, and others. Clinical presentation of frontotemporal dementia associated with parkinsonism is variable at age of symptomatic disease onset, disease duration, symptoms, and their occurrence during the disease course. Clinically, it is often difficult to sort out the different genetic forms of frontotemporal dementia associated with parkinsonism. However, with available clinical genetic testing for known genes, the precise diagnosis can be accomplished in some cases.
AB - Frontotemporal dementia is the second most common dementia among people under the age of 65. Fifty percent of affected patients have an associated family history. Several pathogenic genes have been identified for frontotemporal dementia associated with parkinsonism, including microtubule-associated protein tau, progranulin, and chromatin modifying protein 2B, and fused in sarcoma. It has also been reported that frontotemporal dementia associated with parkinsonism can be linked to chromosome 9p. In addition, there are families with frontotemporal dementia associated with a parkinsonian phenotype but unknown genetic status. Some of these kindreds have been diagnosed clinically as familial progressive supranuclear palsy, hereditary diffuse leukoencephalopathy with axonal spheroids, "overlap" syndrome, and others. Clinical presentation of frontotemporal dementia associated with parkinsonism is variable at age of symptomatic disease onset, disease duration, symptoms, and their occurrence during the disease course. Clinically, it is often difficult to sort out the different genetic forms of frontotemporal dementia associated with parkinsonism. However, with available clinical genetic testing for known genes, the precise diagnosis can be accomplished in some cases.
KW - 9p-linked
KW - Familial
KW - Frontotemporal dementia
KW - MAPT
KW - PGRN
KW - Parkinsonism
UR - http://www.scopus.com/inward/record.url?scp=80855131515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80855131515&partnerID=8YFLogxK
U2 - 10.1007/s12031-011-9568-5
DO - 10.1007/s12031-011-9568-5
M3 - Article
C2 - 21656039
AN - SCOPUS:80855131515
VL - 45
SP - 359
EP - 365
JO - Journal of Molecular Neuroscience
JF - Journal of Molecular Neuroscience
SN - 0895-8696
IS - 3
ER -